Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

PINNEBERG, Germany -- Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) is pushing forward research into cold plasma for the prevention of ventilator-associated pneumonia (VAP). Under the scientific direction of the outstanding expert Prof. Dr. Hortense Slevogt, BREATH scientist at the Hannover Medical School, the innovative project is investigating the safety and efficacy of cold plasma to kill bacteria in the respiratory tract for approval as a therapy. Read More

Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs